At a glance
- Originator Pharmacia Corporation
- Class Antidepressants; Antipsychotics; Anxiolytics; Nicotinic acids; Piperazines
- Mechanism of Action 5-HT1A serotonin receptor agonists; Serotonin 5-HT2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder
Most Recent Events
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 31 Dec 1996 Preclinical development for Depression in Sweden (Unknown route)
- 31 Dec 1996 Preclinical development for Depression in USA (Unknown route)